Sio Gene Therapies Inc. Profile Avatar - Palmy Investing

Sio Gene Therapies Inc.

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize …

Biotechnology
US, New York [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Sio Gene Therapies Inc. (SIOX) to it's peer group.

Peer Group
Loading...
End of SIOX's Analysis
CIK: 1636050 CUSIP: 829399104 ISIN: US8293991043 LEI: - UEI: -
Secondary Listings
SIOX has no secondary listings inside our databases.